13:30 - Proparia - 11 mins (Baz Hamo) - Exfoliation & Dermatology
13:41 - UCB - 11 mins (TBC) - UCB and Pipeline Discussion
13:52 - BMS - 11 mins (A/Prof. John Few) - From bench to bedside: TYK2 inhibition with SOTYKTU into clinical practice
14:03 - Johnson and Johnson - 8 mins (Becky Sweet) - Modification of Tissue Resident Memory cells in Psoriatic Disease with Guselkumab
14:11 - SANOFI - 8 mins (Richard Worrell) - Dermatology pipeline and Type 2 research grants
14:19 - AbbVie - 8 mins (Christine Bailey) - AbbVie's contribution to the advancement of immunology research
14:27 - Novartis - 8 mins (Erin McMeniman) - Can you see me? Development and Validation of Digital Algorithms to Identify Hidradenitis Suppurativa in Queensland
14:35 - Amgen - 8 mins (TBC) - TBC
14:43 - Behringer-Ingelheim - 8 mins (Pablo Fernandez-Penas) - TBC
14:51 - Galderma - 8 mins (TBC) - TBC
Sahra By The River